Atlas Trials

Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study

Clinical trial NCT06888050 · RECRUITING

Trial details

NCT number
NCT06888050
Sponsor
Zhejiang Provincial People's Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
New-onset Type 2 Diabetes
Start date
2025-04-11
Primary completion
2026-06-30
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.